AngioDynamics (ANGO) closed at $6.91 in the latest trading session, marking a -0.72% move from the prior day.
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expand
AngioDynamics (ANGO) closed the most recent trading day at $6.77, moving -1.31% from the previous trading session.
In the most recent trading session, AngioDynamics (ANGO) closed at $6.74, indicating a -0.15% shift from the previous trading day.
AngioDynamics (ANGO) closed the most recent trading day at $6.85, moving +1.33% from the previous trading session.
In the latest trading session, AngioDynamics (ANGO) closed at $6.86, marking a -1.15% move from the previous day.
In the closing of the recent trading day, AngioDynamics (ANGO) stood at $6.21, denoting a +0.65% change from the preceding trading day.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in first-quarter fiscal 2024.

Why Angiodynamics Stock Sank Today

06:15pm, Wednesday, 04'th Oct 2023
The medical device and technology specialist unveiled its latest set of quarterly results. Its bottom line was in the red and only marginally beat estimates.
AngioDynamics (ANGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.06 per share a year ago.

Why AngioDynamics Stock Popped on Monday

01:21pm, Monday, 25'th Sep 2023
An investment bank initiated coverage of the stock with a buy rating this morning. The banker believes AngioDynamics stock could nearly triple over the next year.
AngioDynamics, Inc. posted mixed results in its FY'23 reports, with strong growth in its Med Tech division. The company's focus going forward will be on its Med Tech segment, which has shown high grow
AngioDynamics (ANGO) closed at $8.58 in the latest trading session, marking no change from the prior day.
The FDA's grant of the Breakthrough Device designation for AngioDynamics' (ANGO) AngioVac is likely to remove thrombus and embolic material and minimize blood loss via blood recirculation.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE